Sangamo Therapeutics (0R1D.L) Stock Price
$0.502 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
1 -
Technical
4
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Sangamo Therapeutics, AI stock picks, stock alerts and much more.
0R1D.L AI Stock Analysis
AI stock analysis for 0R1D.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Sangamo Therapeutics (0R1D.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Sangamo Therapeutics (0R1D.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Sangamo Therapeutics (0R1D.L), currently trading at $0.502, will... Sign up to access price prediction.
About 0R1D.L
-
Sangamo Therapeutics, Inc.
-
Symbol
0R1D.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
151.5M
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$394.5 0.3% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$142.1 0.9% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$8.23 1.5% |
5 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$6.64 2.1% |
5 |
 |
Esperion Therapeutics 0IIM.L |
$2.8 2.9% |
6 |
News
0R1D.L Alternative Data
Web Traffic
Sangamo Therapeutics receives an estimated 18094 monthly visitors to sangamo.com, which is up by 6.4% over the last month.
-
Web Traffic
18094
-
Change from Previous Month
6.4%
-
3 Month Change
8.7%
-
YoY Change
8.7%
Twitter Followers
Sangamo Therapeutics has 4,127 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.6% over the last month.
-
Twitter Followers
4127
-
Daily Change
0%
-
1 Month Change
0.6%
-
3 Month Change
1.6%
-
YoY Change
1.6%
Facebook Engagement
Sangamo Therapeutics has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Job Postings
Sangamo Therapeutics currenly has an estimated 4 open job postings, up by 33.3% over the last month.
-
Job Postings
4
-
Daily Change
33.3%
-
1 Month Change
33.3%
-
3 Month Change
100%
-
YoY Change
100%
Reddit Mentions
Sangamo Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
43,671 are following Sangamo Therapeutics on LinkedIn, up by 0.3% over the last month.
-
LinkedIn Followers
43671
-
Daily Change
0.3%
-
1 Month Change
0.3%
-
3 Month Change
1.3%
-
YoY Change
1.3%
Business Outlook
According to employee reviews, the business outlook among employees at Sangamo Therapeutics is 35 out of 100 (bearish).
-
Business Outlook
35
-
Change from Previous Month
0%
-
3 Month Change
7.9%
-
YoY Change
7.9%
LinkedIn Employees
According to LinkedIn, Sangamo Therapeutics has 267 employees, down by -1.1% over the last month.
-
LinkedIn Employees
267
-
Daily Change
1.1%
-
1 Month Change
1.1%
-
3 Month Change
3.6%
-
YoY Change
3.6%
News Mentions
Sangamo Therapeutics was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0R1D.L Financials
0R1D.L Key Metrics
-
Total Revenue
$6.4M
-
Net Income
-$30.6M
-
Earnings per Share
-$0.14
-
Free cash flow
-$26.1M
-
EBITDA
-$29.6M
-
EBITDA Ratio
-4.60277
-
Total Assets
$86.2M
0R1D.L 2-year Revenue & Income
0R1D.L 2-year Free Cash Flow
0R1D.L Technicals
0R1D.L SMA
0R1D.L RSI
FAQ
What's the current price of Sangamo Therapeutics (0R1D.L) Stock?
The price of an Sangamo Therapeutics (0R1D.L) share is $0.502.
What's the market cap of Sangamo Therapeutics?
The current market cap of Sangamo Therapeutics is 151.5M.
What are some stocks similar to Sangamo Therapeutics (0R1D.L) that investors often compare it to?
Sangamo Therapeutics (0R1D.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Esperion Therapeutics.
What is the forecast for Sangamo Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Sangamo Therapeutics' stock price to be around $0.501 in 2026. Starting from the current price of $0.502, this represents a 0.2% change in price, indicating a neutral outlook for the stock.
How to buy Sangamo Therapeutics (0R1D.L) Stock?
Sangamo Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Sangamo Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.